Atlas Trials

The Set-Point Study for Type 2 Diabetes: Evaluating the Use of an Insulin Only Bionic Pancreas System in Type 2 Diabetes

Clinical trial NCT03552523 · COMPLETED

Trial details

NCT number
NCT03552523
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2017-07-28
Primary completion
2018-03-29
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.